Bausch Health Cos
Bausch Health Companies Inc., commonly referred to as Bausch Health, is a prominent global healthcare company headquartered in Canada. Founded in 2013, the company has rapidly established itself in the pharmaceutical and medical device industries, focusing on eye health, gastrointestinal health, and dermatology. With a diverse portfolio of innovative products, Bausch Health is renowned for its commitment to improving patient outcomes through advanced therapies and technologies. Key offerings include prescription medications, over-the-counter products, and surgical devices, all designed to address critical health needs. Bausch Health has achieved significant milestones, including strategic acquisitions that have bolstered its market position. The company continues to be a leader in the healthcare sector, dedicated to enhancing the quality of life for patients worldwide.
DitchCarbon Score
How does Bausch Health Cos's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Bausch Health Cos's score of 40 is higher than 73% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Bausch Health Cos's reported carbon emissions
In 2023, Bausch Health Cos reported total carbon emissions of approximately 49,906,000 kg CO2e for Scope 1, 51,990,000 kg CO2e for Scope 2 (market-based), and 27,107,000 kg CO2e for Scope 3 emissions related to waste generated in operations. This reflects a slight increase in Scope 1 emissions from 46,686,000 kg CO2e in 2022, while Scope 2 emissions (market-based) also rose from 50,513,000 kg CO2e in the previous year. Bausch Health has set ambitious reduction targets, aiming for a 30% decrease in Scope 1 emissions and a 25% reduction in Scope 2 emissions by 2030, using 2022 as the baseline year. Additionally, the company has committed to a 42% reduction in both Scope 1 and Scope 2 emissions by 2030 from a 2020 baseline, as part of its Science Based Targets initiative (SBTi) commitments. These targets align with the global goal of limiting temperature rise to 1.5°C. Bausch Health's climate commitments reflect a proactive approach to minimising its greenhouse gas emissions and contributing to climate change mitigation efforts.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | |
|---|---|---|
| Scope 1 | 46,686,000 | 00,000,000 |
| Scope 2 | 50,513,000 | 00,000,000 |
| Scope 3 | 19,260,000 | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Bausch Health Cos is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
